Can-Fite Biopharma Total Revenue

Can-Fite Biopharma (CANF) currently reports a total revenue of $410K as of December 2025. That compares with $670K in the prior-year period — down 39.9% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Can-Fite Biopharma's total revenue history and peer comparisons.

Can-Fite Biopharma's total revenue decreased from $670K to $410K — a 39.9% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Can-Fite Biopharma's total revenue of $410K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Can-Fite Biopharma reported $410K in total revenue as of December 2025. That compares with $670K in the prior-year period — down 39.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $410K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Can-Fite Biopharma, and consider following CANF for alerts when major investors trade the stock.